nalidixic acid has been researched along with Cronobacter Infections in 37 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Eighty-one women were randomly selected for treatment with nalidixic acid (1 g four times a day) or cephalexin (500 mg four times a day) as therapy for 131 episodes of bacteriuria localized using the antibody-coated bacteria (ACB) test." | 5.05 | A comparison of the efficacy of nalidixic acid and cephalexin in bacteriuric women and their effect on fecal and periurethral carriage of enterobacteriaceae. ( Harding, GK; Hoban, S; Marrie, TJ; Preiksaitis, JK; Ronald, AR; Thompson, L, 1981) |
| "The overall rate of nosocomial infections was at 28% (group 1), 33% (group 2), and 32% (group 3)." | 2.66 | Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli. Study of an outbreak in an intensive care unit. ( Besbes, M; Brun-Buisson, C; Legrand, P; Lemaire, F; Meakins, JL; Montravers, F; Rauss, A; Richard, C; Soussy, CJ, 1989) |
| "Norfloxacin was as effective and safe as trimethoprim-sulfamethoxazole without emergence of resistant bacteria associated with trimethoprim-sulfamethoxazole." | 2.66 | Efficacy of norfloxacin in urinary tract infection biological effects on vaginal and fecal flora. ( Schaeffer, AJ; Sisney, GA, 1985) |
| "The empiric treatment of acute pyelonephritis (APN) with third generation cephalosporins (3GC) or fluoroquinolones (FQ) has been challenged by Escherichia coli resistance reported by community surveillance networks." | 1.40 | Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: rates and predicting factors. ( Caron, F; Choplin-Renard, J; Etienne, M; Pestel-Caron, M; Van Elslande, H, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (56.76) | 18.7374 |
| 1990's | 2 (5.41) | 18.2507 |
| 2000's | 8 (21.62) | 29.6817 |
| 2010's | 6 (16.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, JJ | 1 |
| Ko, WC | 1 |
| Tsai, SH | 1 |
| Yan, JJ | 1 |
| Pérez, A | 1 |
| Canle, D | 1 |
| Latasa, C | 1 |
| Poza, M | 1 |
| Beceiro, A | 1 |
| Tomás, Mdel M | 1 |
| Fernández, A | 1 |
| Mallo, S | 1 |
| Pérez, S | 1 |
| Molina, F | 1 |
| Villanueva, R | 1 |
| Lasa, I | 1 |
| Bou, G | 2 |
| Quiroga, MP | 2 |
| Andres, P | 2 |
| Petroni, A | 2 |
| Soler Bistué, AJ | 1 |
| Guerriero, L | 2 |
| Vargas, LJ | 1 |
| Zorreguieta, A | 1 |
| Tokumoto, M | 1 |
| Quiroga, C | 1 |
| Tolmasky, ME | 1 |
| Galas, M | 2 |
| Centrón, D | 2 |
| Tamang, MD | 1 |
| Seol, SY | 1 |
| Oh, JY | 1 |
| Kang, HY | 1 |
| Lee, JC | 1 |
| Lee, YC | 1 |
| Cho, DT | 1 |
| Kim, J | 1 |
| Ma, J | 1 |
| Zeng, Z | 1 |
| Chen, Z | 1 |
| Xu, X | 2 |
| Wang, X | 2 |
| Deng, Y | 1 |
| Lü, D | 1 |
| Huang, L | 1 |
| Zhang, Y | 1 |
| Liu, J | 1 |
| Wang, M | 3 |
| Guo, Q | 1 |
| Ye, X | 1 |
| Wu, S | 1 |
| Hooper, DC | 1 |
| Handzlik, J | 2 |
| Szymańska, E | 2 |
| Alibert, S | 2 |
| Chevalier, J | 2 |
| Otrębska, E | 2 |
| Pękala, E | 1 |
| Pagès, JM | 2 |
| Kieć-Kononowicz, K | 2 |
| Etienne, M | 1 |
| Van Elslande, H | 1 |
| Choplin-Renard, J | 1 |
| Pestel-Caron, M | 1 |
| Caron, F | 1 |
| Yanat, B | 1 |
| Machuca, J | 2 |
| Díaz-De-Alba, P | 1 |
| Mezhoud, H | 1 |
| Touati, A | 1 |
| Pascual, Á | 2 |
| Rodríguez-Martínez, JM | 1 |
| Agüero, J | 1 |
| Miró, E | 1 |
| Conejo, MDC | 1 |
| Oteo, J | 1 |
| González-López, JJ | 1 |
| Oliver, A | 1 |
| Navarro, F | 1 |
| Martínez-Martínez, L | 1 |
| Albornoz, E | 1 |
| Lucero, C | 1 |
| Romero, G | 1 |
| Rapoport, M | 1 |
| Rodriguez, C | 1 |
| Corso, A | 1 |
| Fang, H | 1 |
| Huang, H | 1 |
| Shi, Y | 1 |
| Hedin, G | 1 |
| Nord, CE | 1 |
| Ullberg, M | 1 |
| Greenwood, D | 1 |
| Baxter, S | 1 |
| Cowlishaw, A | 1 |
| Eley, A | 1 |
| Slater, GJ | 1 |
| Preiksaitis, JK | 1 |
| Thompson, L | 1 |
| Harding, GK | 1 |
| Marrie, TJ | 1 |
| Hoban, S | 1 |
| Ronald, AR | 2 |
| Maqueda Sánchez, S | 1 |
| Naranjo Gómez, P | 1 |
| Alvarez Otero, MJ | 1 |
| García de Lomana Oñate, MT | 1 |
| Muñoz de la Paz, MC | 1 |
| Sierra Barcena, E | 1 |
| Light, RB | 1 |
| Harding, G | 1 |
| Fox, L | 1 |
| Buckwold, FJ | 1 |
| Navia, MM | 1 |
| Ruiz, J | 1 |
| Ribera, A | 1 |
| de Anta, MT | 1 |
| Vila, J | 1 |
| Robert, J | 1 |
| Cambau, E | 1 |
| Grenet, K | 1 |
| Trystram, D | 1 |
| Péan, Y | 1 |
| Fiévet, MH | 1 |
| Jarlier, V | 1 |
| Langsádl, L | 1 |
| Polívková-Konícková, L | 1 |
| Roubínek, F | 1 |
| Ball, AP | 1 |
| Sorice, F | 1 |
| Ortona, L | 1 |
| Pizzigallo, E | 1 |
| Liassine, N | 1 |
| Chelfi, A | 1 |
| Rahal, K | 1 |
| Brun-Buisson, C | 1 |
| Legrand, P | 1 |
| Rauss, A | 1 |
| Richard, C | 1 |
| Montravers, F | 1 |
| Besbes, M | 1 |
| Meakins, JL | 1 |
| Soussy, CJ | 1 |
| Lemaire, F | 1 |
| Schaeffer, AJ | 1 |
| Sisney, GA | 1 |
| Esko, E | 1 |
| Renkonen, OV | 1 |
| van der Waaij, D | 1 |
| Berghuis-de Vries, JM | 1 |
| Brühl, P | 1 |
| Schmidt, HJ | 1 |
| Wilfert, JN | 1 |
| Barrett, FF | 1 |
| Ewing, WH | 1 |
| Finland, M | 1 |
| Kass, EH | 1 |
| Wilkowske, CJ | 1 |
| Washington, JA | 2 |
| Martin, WJ | 1 |
| Ritts, RE | 2 |
| Williams, TW | 1 |
| Sailer, JE | 1 |
| Viroslav, J | 1 |
| Knight, V | 1 |
| Glasgow, N | 1 |
| Moreland, N | 1 |
| Birk, RJ | 1 |
| Bergfors, S | 1 |
| Burman, LG | 1 |
| Eklöf, PH | 1 |
| Nordström, K | 1 |
| Tärnvik, A | 1 |
| Modde, H | 1 |
| Bohus, J | 1 |
| Lascuráin, A | 1 |
| Ruíz Velasco, V | 1 |
| Ledesma Pavía, LE | 1 |
| Ledesma García, T | 1 |
| Eykyn, SJ | 1 |
| Phillips, I | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized,Double-Blind,Placebo-Controled Trial of Selective Digestive Decontamination Using Oral Gentamicin and Oral Polymyxin E for Eradication of Carbapenem-Resistant Klebsiella Pneumoniae Carriage[NCT00753558] | 0 participants | Interventional | 2008-11-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for nalidixic acid and Cronobacter Infections
| Article | Year |
|---|---|
Advances in antibiotics.
Topics: Adult; Anti-Bacterial Agents; Cephaloridine; Enterobacteriaceae Infections; Fusidic Acid; Gentamicin | 1969 |
3 trials available for nalidixic acid and Cronobacter Infections
| Article | Year |
|---|---|
A comparison of the efficacy of nalidixic acid and cephalexin in bacteriuric women and their effect on fecal and periurethral carriage of enterobacteriaceae.
Topics: Antibody-Coated Bacteria Test, Urinary; Bacteriuria; Carrier State; Cephalexin; Enterobacteriaceae I | 1981 |
Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli. Study of an outbreak in an intensive care unit.
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Colistin; Cross Infection; Disease Outbreaks; Dr | 1989 |
Efficacy of norfloxacin in urinary tract infection biological effects on vaginal and fecal flora.
Topics: Adult; Anal Canal; Anti-Infective Agents, Urinary; Bacteriuria; Drug Combinations; Drug Resistance, | 1985 |
33 other studies available for nalidixic acid and Cronobacter Infections
| Article | Year |
|---|---|
Prevalence of plasmid-mediated quinolone resistance determinants QnrA, QnrB, and QnrS among clinical isolates of Enterobacter cloacae in a Taiwanese hospital.
Topics: Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobact | 2007 |
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Carrier Proteins; Cloning, Molecular; DNA, Bacte | 2007 |
Complex class 1 integrons with diverse variable regions, including aac(6')-Ib-cr, and a novel allele, qnrB10, associated with ISCR1 in clinical enterobacterial isolates from Argentina.
Topics: Alleles; Amino Acid Sequence; Argentina; Bacterial Proteins; Base Sequence; beta-Lactamases; Cross I | 2007 |
Plasmid-mediated quinolone resistance determinants qnrA, qnrB, and qnrS among clinical isolates of Enterobacteriaceae in a Korean hospital.
Topics: Amino Acid Sequence; Base Sequence; beta-Lactam Resistance; beta-Lactamases; DNA Primers; DNA, Bacte | 2008 |
High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals.
Topics: Acetyltransferases; Adolescent; Adult; Aged; Animals; Animals, Domestic; Anti-Bacterial Agents; Bact | 2009 |
New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis.
Topics: Amino Acid Sequence; Anti-Infective Agents; Bacterial Proteins; Base Sequence; Conjugation, Genetic; | 2009 |
Search for new tools to combat Gram-negative resistant bacteria among amine derivatives of 5-arylidenehydantoin.
Topics: Amines; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Enterobacter aerogenes; Enterob | 2013 |
Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: rates and predicting factors.
Topics: Acute Disease; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Catchment Area, Heal | 2014 |
Characterization of Plasmid-Mediated Quinolone Resistance Determinants in High-Level Quinolone-Resistant Enterobacteriaceae Isolates from the Community: First Report of qnrD Gene in Algeria.
Topics: Algeria; Anti-Bacterial Agents; Clone Cells; Community-Acquired Infections; Drug Resistance, Bacteri | 2017 |
Prevalence of quinolone resistance mechanisms in Enterobacteriaceae producing acquired AmpC β-lactamases and/or carbapenemases in Spain.
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Drug Resistance, Multiple, Bacterial; E | 2017 |
Prevalence of Plasmid-Mediated Quinolone Resistance Genes in Clinical Enterobacteria from Argentina.
Topics: Anti-Bacterial Agents; Argentina; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Bacterial; Ent | 2017 |
Prevalence of qnr determinants among extended-spectrum beta-lactamase-positive Enterobacteriaceae clinical isolates in southern Stockholm, Sweden.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; DNA Gyrase; DNA Topoisomerase IV; DNA, B | 2009 |
Amine-alkyl derivatives of hydantoin: new tool to combat resistant bacteria.
Topics: Amines; Anti-Bacterial Agents; Bacterial Proteins; Carrier Proteins; Drug Resistance, Multiple, Bact | 2011 |
Antibacterial activity of ciprofloxacin in conventional tests and in a model of bacterial cystitis.
Topics: Anti-Infective Agents, Urinary; Ciprofloxacin; Cystitis; Dose-Response Relationship, Drug; Drug Resi | 1984 |
[Treatment with intravenous nalidixic acid in infections with gram negative microorganisms].
Topics: Adolescent; Adult; Aged; Enterobacteriaceae Infections; Female; Humans; Infusions, Parenteral; Male; | 1980 |
Epidemiologic features of urinary infections due to enterobacteriaceae resistant to nalidixic acid and trimethoprim.
Topics: Adult; Aged; Aging; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; Enterobacteriace | 1981 |
Analysis of the mechanisms of quinolone resistance in clinical isolates of Citrobacter freundii.
Topics: Amino Acid Sequence; Anti-Infective Agents; Bacterial Outer Membrane Proteins; Ciprofloxacin; Citrob | 1999 |
Trends in quinolone susceptibility of Enterobacteriaceae among inpatients of a large university hospital: 1992-98.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteria | 2001 |
[A comparison of the effects of three urinary infection chemotherapeutics - nalidixic, oxolinic, and pipemidic acids (author's transl)].
Topics: Animals; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitiv | 1979 |
Serratia marcescens infections--selection of an antibiotic.
Topics: Aminoglycosides; Anti-Bacterial Agents; Enterobacteriaceae Infections; Humans; Microbial Sensitivity | 1976 |
[Further aspects of combination antibiotic therapy. Critical review and personal case studies].
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Brucellosis; Drug Interactions; Drug Thera | 1975 |
[Resistance to new quinolones among the enterobacteria].
Topics: Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Nalidixic Aci | 1992 |
Comparative in vitro activity of norfloxacin and seven other antimicrobial agents against clinical isolates from urinary tract infections.
Topics: Anti-Infective Agents, Urinary; Cefaclor; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; | 1985 |
Selective elimination of Enterobacteriaceae species from the digestive tract in mice and monkeys.
Topics: Administration, Oral; Animals; Candida albicans; Digestive System; Enterobacteriaceae; Enterobacteri | 1974 |
[The effect of nalidixic acid on the course of experimental pyelonephritis under the influence of resistance-affecting drugs].
Topics: Animals; Antibodies; Antibody Formation; Chemical Phenomena; Chemistry; Dehydroepiandrosterone; Dise | 1970 |
Serratia marcescens: biochemical, serological, and epidemiological characteristics and antibiotic susceptibility of strains isolated at Boston City Hospital.
Topics: Boston; Cephalosporins; Cross Infection; Culture Media; Drug Resistance, Microbial; Enterobacteriace | 1970 |
Serratia marcescens. Biochemical characteristics, antibiotic susceptibility patterns, and clinical significance.
Topics: Ampicillin; Anti-Bacterial Agents; Cephalothin; Chloramphenicol; Culture Techniques; Enterobacteriac | 1970 |
Serratia marcescens as a postoperative pathogen.
Topics: Ampicillin; Anti-Bacterial Agents; Carbenicillin; Cephalothin; Chloramphenicol; Endocarditis, Bacter | 1971 |
Bacteriologic and epidemiologic characteristics of Enterobacter hafniae and Enterobacter liquefaciens.
Topics: Adolescent; Adult; Aged; Ampicillin; Carbenicillin; Cephalosporins; Child; Child, Preschool; Chloram | 1971 |
Transferable and non-transferable drug resistance in enteric bacteria isolated from urinary specimens in Northern Sweden.
Topics: Adolescent; Adult; Aged; Ampicillin; Bacteria; Child; Child, Preschool; Cross Reactions; Culture Med | 1972 |
[Diseases caused by Serratia marcescens (Prodigiosus)].
Topics: Bacterial Infections; Carbenicillin; Chloramphenicol; Cross Infection; Enterobacteriaceae Infections | 1972 |
A new screening method for proof of R factors transfer.
Topics: Child, Preschool; Chloramphenicol; Conjugation, Genetic; Czechoslovakia; Drug Resistance, Microbial; | 1974 |
[Use of nalidixic acid in various pelvic infectious processes].
Topics: Adolescent; Adult; Cesarean Section; Enterobacteriaceae Infections; Evaluation Studies as Topic; Fem | 1973 |